Cytomegalovirus (CMV) infection is associated with allograft rejection but the mechanisms behind are poorly defined yet. Although cross-reactivity of T cells to alloantigen and CMV has been hypothesized, direct evidence in patients is lacking. In this observational cohort study, we tested the pre-transplant effector/memory T cell response to CMV peptide pools and alloantigen in 78 living donor/recipient pairs using the interferon-gamma Enzyme-Linked ImmunoSpot (ELISPOT) assay. To prove the hypothesis of cross-reactivity, we analyzed by applying next-generation sequencing the T cell receptor ß (TCR- ß) repertoire of CMV- and alloantigen-reactive T cells enriched from peripheral pre-transplant blood of 11 CMV-seropositive and HLA class I mismatched patients. Moreover, the TCR-repertoire was also analyzed in the allograft biopsies of those patients. There was a significant association between the presence of pre-transplant CMV immediate-early protein 1 (IE-1)-specific effector/memory T cells and acute renal allograft rejection and function (p = 0.01). Most importantly, we revealed shared TCR-ß sequences between CMV-IE1 and donor alloantigen-reactive T cells in all pre-transplant peripheral blood samples analyzed in CMV-seropositive patients who received HLA class I mismatched grafts. Identical TCR sequences were also found in particular in post-transplant allograft biopsies of patients with concomitant CMV infection and rejection. Our data show the presence of functional, cross-reactive T cells and their clonotypes in peripheral blood and in kidney allograft tissue. It is therefore likely that CMV-donor cross-reactivity as well as CMV specific T cell elicited inflammation is involved in the processes that affect allograft outcomes.

BIH Centre for Regenerative Therapies Berlin Centre for Advanced Therapies Charité University Medicine Berlin Berlin Germany

CLIP Childhood Leukaemia Investigation Prague Department of Paediatric Haematology and Oncology 2nd Faculty of Medicine Charles University Prague and University Hospital Motol Prague Czechia

Department of Immunogenetics Institute for Clinical and Experimental Medicine Prague Czechia

Department of Nephrology Transplant Centre Institute for Clinical and Experimental Medicine Prague Czechia

Department of Paediatric Haematology and Oncology 2nd Faculty of Medicine and Motol University Hospital Charles University Prague Czechia

Department of Transplant Pathology Transplant Centre Institute for Clinical and Experimental Medicine Prague Czechia

Department of Transplant Surgery Institute for Clinical and Experimental Medicine Prague Czechia

Transplant Laboratory Institute for Clinical and Experimental Medicine Prague Czechia

Transplant Laboratory Institute for Clinical and Experimental Medicine Prague Czechia Department of Nephrology Transplant Centre Institute for Clinical and Experimental Medicine Prague Czechia

000      

00000naa a2200000 a 4500

001      

bmc20028772

003      

CZ-PrNML

005      

20210114155133.0

007      

ta

008      

210105s2019 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3389/fimmu.2019.02549 $2 doi

035    __

$a (PubMed)31736968

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Stranavova, Lucia $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czechia.

245    10

$a Heterologous Cytomegalovirus and Allo-Reactivity by Shared T Cell Receptor Repertoire in Kidney Transplantation / $c L. Stranavova, O. Pelak, M. Svaton, P. Hruba, E. Fronkova, A. Slavcev, K. Osickova, J. Maluskova, P. Hubacek, J. Fronek, P. Reinke, HD. Volk, T. Kalina, O. Viklicky,

520    9_

$a Cytomegalovirus (CMV) infection is associated with allograft rejection but the mechanisms behind are poorly defined yet. Although cross-reactivity of T cells to alloantigen and CMV has been hypothesized, direct evidence in patients is lacking. In this observational cohort study, we tested the pre-transplant effector/memory T cell response to CMV peptide pools and alloantigen in 78 living donor/recipient pairs using the interferon-gamma Enzyme-Linked ImmunoSpot (ELISPOT) assay. To prove the hypothesis of cross-reactivity, we analyzed by applying next-generation sequencing the T cell receptor ß (TCR- ß) repertoire of CMV- and alloantigen-reactive T cells enriched from peripheral pre-transplant blood of 11 CMV-seropositive and HLA class I mismatched patients. Moreover, the TCR-repertoire was also analyzed in the allograft biopsies of those patients. There was a significant association between the presence of pre-transplant CMV immediate-early protein 1 (IE-1)-specific effector/memory T cells and acute renal allograft rejection and function (p = 0.01). Most importantly, we revealed shared TCR-ß sequences between CMV-IE1 and donor alloantigen-reactive T cells in all pre-transplant peripheral blood samples analyzed in CMV-seropositive patients who received HLA class I mismatched grafts. Identical TCR sequences were also found in particular in post-transplant allograft biopsies of patients with concomitant CMV infection and rejection. Our data show the presence of functional, cross-reactive T cells and their clonotypes in peripheral blood and in kidney allograft tissue. It is therefore likely that CMV-donor cross-reactivity as well as CMV specific T cell elicited inflammation is involved in the processes that affect allograft outcomes.

650    _2

$a dospělí $7 D000328

650    _2

$a alografty $7 D064591

650    _2

$a biopsie $7 D001706

650    _2

$a kohortové studie $7 D015331

650    _2

$a Cytomegalovirus $x imunologie $7 D003587

650    12

$a cytomegalovirové infekce $x etiologie $x genetika $x imunologie $x patologie $7 D003586

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    12

$a imunologická paměť $7 D007156

650    _2

$a isoantigeny $x genetika $x imunologie $7 D007519

650    12

$a transplantace ledvin $7 D016030

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    12

$a receptory antigenů T-buněk alfa-beta $x imunologie $7 D016693

650    12

$a T-lymfocyty $x mikrobiologie $x patologie $7 D013601

655    _2

$a klinické zkoušky $7 D016430

655    _2

$a časopisecké články $7 D016428

655    _2

$a pozorovací studie $7 D064888

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Pelak, Ondrej $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czechia.

700    1_

$a Svaton, Michael $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czechia.

700    1_

$a Hruba, Petra $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czechia.

700    1_

$a Fronkova, Eva $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czechia.

700    1_

$a Slavcev, Antonij $u Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czechia.

700    1_

$a Osickova, Klara $u Department of Nephrology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia.

700    1_

$a Maluskova, Jana $u Department of Transplant Pathology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia.

700    1_

$a Hubacek, Petr $u Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czechia.

700    1_

$a Fronek, Jiri $u Department of Transplant Surgery, Institute for Clinical and Experimental Medicine, Prague, Czechia.

700    1_

$a Reinke, Petra $u BIH Centre for Regenerative Therapies, Berlin Centre for Advanced Therapies, Charité University Medicine Berlin, Berlin, Germany.

700    1_

$a Volk, Hans-Dieter $u BIH Centre for Regenerative Therapies, Berlin Centre for Advanced Therapies, Charité University Medicine Berlin, Berlin, Germany.

700    1_

$a Kalina, Tomas $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University Prague and University Hospital Motol, Prague, Czechia.

700    1_

$a Viklicky, Ondrej $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czechia. Department of Nephrology, Transplant Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia.

773    0_

$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 10, č. - (2019), s. 2549

856    41

$u https://pubmed.ncbi.nlm.nih.gov/31736968 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20210105 $b ABA008

991    __

$a 20210114155132 $b ABA008

999    __

$a ok $b bmc $g 1609107 $s 1119952

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2019 $b 10 $c - $d 2549 $e 20191031 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405

LZP    __

$a Pubmed-20210105